Nissan Chemical Corporation
4021
Classifica tra le azioni
#2672
Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse... Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.
Prezzo delle azioni
$53.59
Capitalizzazione di mercato
$7.15B
Variazione (1 giorno)
0.15%
Variazione (1 anno)
54.63%
Paese
JP
Scambia Nissan Chemical Corporation (4021)
Categoria
Basic Materials
Rapporto P/E per Nissan Chemical Corporation (4021)
Rapporto P/E al October 2026 TTM: 21.93
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Nissan Chemical Corporation, il rapporto P/E attuale (TTM) è 21.93. Alla fine del 2024, il rapporto P/E era 21.19.
Storico del rapporto P/E per Nissan Chemical Corporation da 2000 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 21.93 | 54.56% |
| 2025 | 14.19 | -33.04% |
| 2024 | 21.19 | 3.05% |
| 2023 | 20.56 | -22.69% |
| 2022 | 26.59 | 4.27% |
| 2021 | 25.50 | 35.99% |
| 2020 | 18.75 | -27.31% |
| 2019 | 25.80 | 5.24% |
| 2018 | 24.52 | 18.77% |
| 2017 | 20.64 | 2.04% |
| 2016 | 20.23 | -7.36% |
| 2015 | 21.84 | 43.93% |
| 2014 | 15.17 | 14.55% |
| 2013 | 13.24 | 9.97% |
| 2012 | 12.04 | 6.34% |
| 2011 | 11.33 | -35.93% |
| 2010 | 17.68 | 23.27% |
| 2009 | 14.34 | 16.28% |
| 2008 | 12.33 | -38.88% |
| 2007 | 20.18 | -26.55% |
| 2006 | 27.47 | 77.51% |
| 2005 | 15.48 | -21.33% |
| 2004 | 19.67 | -11.06% |
| 2003 | 22.12 | -44.71% |
| 2002 | 40.00 | 28.48% |
| 2001 | 31.13 | -50.75% |
| 2000 | 63.21 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| 50.73 | 131.29% |
TW
|
|
| 21.21 | -3.31% |
JP
|
|
| - | - |
DE
|
|
| -6.52 | -129.75% |
SA
|
|
| 12.24 | -44.21% |
CN
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.